INBX
INBX
US45720N1037
Inhibrx Biosciences, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.4B EUR
1.39B EUR
982.05M EUR
1.15B EUR
Enterprise Value
1.41B EUR
1.44B EUR
1B EUR
1.13B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-10.85x
--
--
--
Price to Sales
-
--
755.42x
885.87x
Price to Book
--
--
--
144.08x
EV/Revenue
--
--
770.22x
872.63x
EV/EBITDA
-11.25x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-6.09%
-9.46%
-13.43%
-8.15%
ende